Greater than one third of all HIV infections and AIDS cases are related directly or indirectly to injection drug use [1, 2]. While it is clear that drug use itself plays an important role in the spread of HIV infection, the effects of the drugs on HIV disease progression are not fully understood and various epidemiologic, animal and in vitro studies have provided some conflicting results. In view of the confounding variables in human epidemiologic studies and problems in previous animal studies investigating this issue, additional studies are needed to determine the role of opioids in contributing to the pathogenesis of HIV infection and the development of AIDS associated CMS disorders.
The Specific Aim of this core is to carry out Experimental Animal Protocols in Indian rhesus macaques, to perform certain clinical, virologic, and immunologic measurements and to provide a mechanism of distribution of samples from the ongoing animal protocols to projects and Core D (Immunohistochemical Core) for further analysis. The Core will provide housing, care, scheduled drug treatment interventions, sample collections, clinical and virologic data collection for two sequential protocols to determine the effects of opioids on the pathogenesis of SIV infection and the development of CMS disease. The activities of this core are essential to the overall performance of this Program Project especially since Project 1,2,3, and 4 rely heavily on the samples from rhesus macaques in various treatment groups as well as on clinical and virologic data generated in this core. The proposed studies that this Core will support are critical for our understanding of how opioid drug abuse affects the course of HIV disease progression.. The experimental design of the Experimental Animal Protocol should lead to definitive answers regarding the role of opiates drugs of abuse in altering the pathogenesis of HIV/SIV and in contributing to CMS disease. These studies supported by this Core should provide important insights regarding pathogenesis and therapeutic approaches in patients with HIV infection, particularly those who are opiate drug abusers.
|Regan, Patrick M; Langford, Dianne; Khalili, Kamel (2016) Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV Pathogenesis. J Cell Physiol 231:976-85|
|Gabunia, Khatuna; Ellison, Stephen; Kelemen, Sheri et al. (2016) IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages. Am J Pathol 186:1361-74|
|Cornwell, William D; Wagner, Wendeline; Lewis, Mark G et al. (2016) Effect of chronic morphine administration on circulating dendritic cells in SIV-infected rhesus macaques. J Neuroimmunol 295-296:30-40|
|Song, Changcheng; Wang, Qing; Song, Changzheng et al. (2015) Nucleocytoplasmic shuttling of valosin-containing protein (VCP/p97) regulated by its N domain and C-terminal region. Biochim Biophys Acta 1853:222-32|
|Cabral, Guy A; Rogers, Thomas J; Lichtman, Aron H (2015) Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. J Neuroimmune Pharmacol 10:193-203|
|Pitcher, Jonathan; Abt, Anna; Myers, Jaclyn et al. (2014) Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction. J Clin Invest 124:656-69|
|Bednar, Filip; Song, Changcheng; Bardi, Giuseppe et al. (2014) Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1. J Immunol 192:5305-13|
|Cornwell, William D; Lewis, Mark G; Fan, Xiaoxuan et al. (2013) Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques. J Neuroimmunol 265:43-50|
|Dave, Rajnish S (2012) Morphine affects HIV-induced inflammatory response without influencing viral replication in human monocyte-derived macrophages. FEMS Immunol Med Microbiol 64:228-36|
|Rogers, Thomas J (2012) The molecular basis for neuroimmune receptor signaling. J Neuroimmune Pharmacol 7:722-4|
Showing the most recent 10 out of 18 publications